Duke Street Capital, the pan-European fund management group, has appointed Michael Fabich and Bernd Aundrup as chairman of the new German advisory board and operating partner, respectively. These new appointments complement the establishment of the new Duke Street private equity team, focused on the German Market and headed by Ervin Schellenberg
Fabich has over 20 years experience in the banking and consulting sector in Germany. He was most recently a member of the board of Salomon Brothers and co-head of investment banking at Schroder Salomon Smith Barney in Germany. Previously he was co-head of M&A Germany for Dresdner Kleinwort Benson prior to which he founded Schrder Munchmeyer Hengst Corporate Finance where he was a shareholder and managing partner.
Aundrup was chief executive of Degussa’s Asta Medica from 1997 to 2002. From 1991 to 1997 he was MD of ICI Pharma/Zeneca GmbH. Previously he held a variety of international management positions within the Bayer Group in Europe, North and South America.